In 2018, a number of Korean pharma medicines expected to acquire approval from U.S. FDA

In 2018, there is a high expectation on the Korean pharmaceutical industry. Along with recent technology exports to other countries, it has been expected there would be a number of products to emerge as a medicine to enter advanced markets, like U.S.

△ Series of technology exports; 3 cases in a month = Last year, there were 11 technology cases exported by Korean pharmaceutical companies to for...